scispace - formally typeset
A

Anna A. Shtro

Publications -  52
Citations -  734

Anna A. Shtro is an academic researcher. The author has contributed to research in topics: Virus & Medicine. The author has an hindex of 14, co-authored 35 publications receiving 520 citations.

Papers
More filters
Journal ArticleDOI

Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.

TL;DR: It is demonstrated that influenza viruses can be inhibited by adamantyl-azoles and thus have potential for developing antiviral agents with an alternate mechanism of action.
Journal ArticleDOI

Anti-viral activity of (-)- and (+)-usnic acids and their derivatives against influenza virus A(H1N1)2009.

TL;DR: In this article, the antiviral activity of usnic acid and its derivatives against the pandemic influenza virus A(H1N1)pdm09 was studied for the first time, and a total of 26 compounds representing (+) and (-) isomers of usnik acid and their derivates were tested for cytotoxicity and anti-viral activity in MDCK cells by microtetrazolium test and virus yield assay, respectively.
Journal ArticleDOI

Broad range of inhibiting action of novel camphor-based compound with anti-hemagglutinin activity against influenza viruses in vitro and in vivo

TL;DR: Anti-influenza activity of camphor derivative 1,7,7-trimethylbicyclo (camphecene) is reported, showing the compound appeared the most effective when added at the early stages of viral life cycle and in direct hemagglutinin inhibition tests camphecenes was shown to decrease the activity of HA's of influenza viruses A and B.
Journal ArticleDOI

Novel derivatives of usnic acid effectively inhibiting reproduction of influenza A virus

TL;DR: It is revealed that (-)-usnic acid exhibited higher antiviral activity than its (+)-enantiomer, but in the pairs of enantiomer derivatives such as enamines, pyrazoles and chalcones, the (+-enantiomers were more potent inhibitors of the virus.
Journal ArticleDOI

Synthesis and in vitro study of novel borneol derivatives as potent inhibitors of the influenza A virus.

TL;DR: The design and synthesis of a series of novel heterocyclic derivatives of (–)-borneol and (–-isoborneol as potent inhibitors of the influenza A virus are presented.